|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 06, 2018 ) The Global Generic Drugs Market should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021.
A recent publication released by Research Cosmos predicts the global generics market to reach $533 billion from 2016-2021, driven by pharmaceutical drugs facing patent expiry, the pressure to control healthcare costs, the rise of biosimilar drug technologies, and high-growth market activity in emerging regions.
Research Cosmos's Global Market for Generic Drugs reports the generics sector, which has consistently outperformed sales in the original brand market for the past five years, appears set for continued double-digit growth as cost containment efforts intensify and many of the great blockbusters mature and go off patent.
Browse details of 155 pages research report on Global Generic Drugs Market @ https://www.researchcosmos.com/reports/global-generic-drugs-market-analysis-with-forecasts-to-2022-growth-opportunities/1057077352
Research Highlights
Generics, which already dominate several leading classes, are rapidly becoming the first-line option in many key therapy areas as fewer new pharmaceutical products reach market.
Generic sales should register consistent growth in the five major European markets, aided by the loss of patent protection on an anticipated $20 billion of marketed products.
The BRIC nations (Brazil, Russia, India and China) are among rising centers of generic activity.
The generic drug markets in the BRIC region are taking off, as evidenced by the region's leading 10.7% CAGR from 2016-2021. In China, generic sales are easily outpacing the overall pharma market growth. The increasing sophistication among domestic producers seems to be galvanizing the growth of generics.
Patent Protection Loss is Generics Gain
The value of small-molecule products facing loss of patent expiry in developed markets from 2014 to 2018 is estimated at $121 billion, compared to $154 billion from 2009 to 2013.
The price of a generic copy may be around 60% of the original brand immediately after patent loss, while after a year, when several generic copies have appeared, the average price may have fallen to less than 20% of the original. Research Cosmos predicts the global generics market will capitalize as name drugs fall off, and continue to grow at an annual rate significantly higher than the pharmaceutical sector overall.
Avail Sample Market Brochure of the report for more information to evaluate report usefulness, Get a Copy @ https://www.researchcosmos.com/request/1057077352
Report Scope:
This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20+ generics companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
Report Includes:
1. An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD
2. Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
3. Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition
4. Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity
5. Profiles of major players and leading generics companies
6. A look at recent merger and acquisition activity
Inquire before buying @ https://www.researchcosmos.com/inquire/1057077352
About Research Cosmos:
Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
Contact Us:
Dani Rodriguez
Sales Manager
Research Cosmos
dani@researchcosmos.com
# - +1 888 709 8757
Research Cosmos
Dani
+1 888 709 8757
dani@researchcosmos.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
